ѻý

Endocrine Disruptors in Paper Straws; Wegovy's CV Benefit; Stroke and Infertility Tx

<ѻý class="mpt-content-deck">— News and commentary from the endocrinology world
MedpageToday
Endo Break over a computer rendering of a man with illustrated body organs.

Eco-friendly paper and bamboo straws were than straws made out of other materials. Researchers determined that stainless-steel straws seemed to be the most sustainable alternative, since they can be reused, do not contain PFAS, and can be fully recycled. (Food Additives & Contaminants)

In related news, Asian Americans had compared with all other races and ethnicities. (Environmental Science & Technology)

When monitoring , home-based monitoring was deemed non-inferior to hospital-controlled monitoring. (The Lancet)

After menopause, women with insomnia and stressful life events were more likely . (Journal of the American Heart Association)

If all eligible U.S. adults were put on 2.4 mg semaglutide (Wegovy), there would be a projected 1.81% absolute risk reduction in over 10 years -- translating to about 1.5 million prevented events. (Cardiovascular Drugs and Therapy)

Wall Street analysts expect the will make it on to the next list of drugs for Medicare price negotiation. (CNBC)

A safety committee for the European Medicines Agency recommended in pregnancy due to the risks for neurodevelopmental disorders in newborns; the drug is indicated for epilepsy, migraine, and in combination with phentermine (Qsymia) for weight loss. (Reuters)

There's a in patients with hyperglycemia and first-episode and drug-naïve major depression. (BMC Psychiatry)

Women who tended to have increased stroke hospitalizations in the months after delivery. (JAMA Network Open)

Could hold promise as an anti-diabetic agent? (Life Metabolism)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.